Literature DB >> 18023867

Flow cytometric mean fluorescence intensity: the biophysics behind the number.

Denise A Wells, Michael R Loken.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18023867     DOI： 10.1016/j.leukres.2007.10.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  5 in total

1.  High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.

Authors:  Roland B Walter; Todd A Alonzo; Robert B Gerbing; Phoenix A Ho; Franklin O Smith; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Janet L Franklin; Craig A Hurwitz; Michael R Loken; Soheil Meshinchi
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

2.  CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.

Authors:  Jessica A Pollard; Michael Loken; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Richard Aplenc; Irwin D Bernstein; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  J Clin Oncol       Date:  2016-01-19       Impact factor: 44.544

3.  CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.

Authors:  Jatinder K Lamba; Lata Chauhan; Miyoung Shin; Michael R Loken; Jessica A Pollard; Yi-Cheng Wang; Rhonda E Ries; Richard Aplenc; Betsy A Hirsch; Susana C Raimondi; Roland B Walter; Irwin D Bernstein; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  J Clin Oncol       Date:  2017-06-23       Impact factor: 44.544

4.  CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Authors:  Lata Chauhan; Miyoung Shin; Yi-Cheng Wang; Michael Loken; Jessica Pollard; Richard Aplenc; Betsy A Hirsch; Susana Raimondi; Rhonda E Ries; Irwin D Bernstein; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi; Jatinder K Lamba
Journal:  JCO Precis Oncol       Date:  2019-05-23

5.  Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy.

Authors:  Leslie Mortland; Todd A Alonzo; Roland B Walter; Robert B Gerbing; Amit K Mitra; Jessica A Pollard; Michael R Loken; Betsy Hirsch; Susana Raimondi; Janet Franklin; Stanley Pounds; Xueyuan Cao; Jeffrey E Rubnitz; Raul C Ribeiro; Alan Gamis; Soheil Meshinchi; Jatinder K Lamba
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.